In one trial, patients taking Tirzepatide lost an average of 21% of their body weight compared to 15% with Semaglutide
Novo Nordisk, Denmark) in combination with empagliflozin (blinded to participants, caregivers, examiners and outcome assessors) or tablet placebo treatment (blinded to participants, caregivers, examiners and outcome assessors)
By activating GLP-1 receptors throughout your body, semaglutide: Increases Insulin Release: When blood sugar rises after meals, semaglutide signals the pancreas to release more insulin, helping move glucose from blood into cells
Lefebvre B, Vandewalle B, Balavoine AS, Queniat G, Moerman E, Vantyghem MC, et al
For some, traditional methods like dieting and gym memberships provide the desired results, while others seek medical assistance to achieve their goals